Non alcoholic fatty liver(NAFLD). Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Control group: the detection of Non-alcoholic fatty¬ liver ( NAFLD) by Ultrasound Images (grade 1 or 2 or 3 ) with body mass index(BMI) Less than or equal 27 will be treated with conv
Treatment - Drugs
Control group: the detection of Non-alcoholic fatty¬ liver ( NAFLD) by Ultrasound Images (grade 1 or 2 or 3 ) with body mass index(BMI) Less than or equal 27 will be treated with conventional medicin
Intervention group: NAFLD Patients has Body Mass Index (BMI less than 27) treated with diet based on Iranian traditional medicine and NAFLD patient has body mass index (BMI) greater than 27 and less
Sponsors
Vice chancellor for research of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 20 to 60 years? the detection of Non-alcoholic fatty liver(NAFLD)by Ultrasound Images (grade 1 or 2 or 3 ). Exclusion criteria: diabetes; heart disease; hypertension; over weight(BMI greater than 30 ). familial hyperlipidemia; active alcohol or addiction; discourage patients from continuing to participate in the plan; Breastfeeding; Pregnancy; Any other chronic diseases such as kidney stones, gallstones, cardiovascular surgery; abdominal surgery; CVA; acute hepatitis; acute Pancreatitis; major Surgery during the last 6 months and also any surgery on the liver and gallbladder. Rapid weight loss during the last 3 months for any reason. Drop Out Criteria: Any medication side effects during treatment; Other acute illnesses during the study period who had liver adverse impact on yield: Such as gallstones and surgery and general anesthesia and drugs with liver toxicity; Increase in liver enzymes (AST, ALT) and Fasting blood sugar (FBS) during the study period; Consent to continue participating in the study; Alcohol and alcoholic beverages during the study period; Drug use is incorrect; Failure to follow the prescribed diet; Not see the patient during follow up; pregnancy and breastfeeding women participating in the project.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measure levels of liver enzymes (AST , ALT). Timepoint: Before the intervention; 6 weeks after the intervention;End of the intervention (3 months). Method of measurement: Autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ultrasound Images of liver;Fatty tissue infiltration in liver (grade 1 or 2 or 3 ). Timepoint: Before the intervention;6 weeks after the intervention ;End of the intervention (3 months). Method of measurement: The grading of fatty liver infiltration of fat tissue based on ultrasound by one radiologist.;Body mass index (BMI). Timepoint: Before the intervention;6 weeks after the intervention ;End of the intervention (3 months). Method of measurement: Weight and height measurements by one person in the same center. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholam reza Ghayour razmgah
Faculty of Traditional Medicine
Outcome results
None listed